tomhilsen Wednesday, 04/10/19 11:25:40 AM Re: None Post # of 4721 Working capital is 30 cents per share. Book value is 33 cents per share. Current PPS is 37 cents. Very little value is being placed on NSI-189 or the stem cell lines. If InVivo gets going again they will need stem cells. I wonder whether the two companies ,CUR and NVIV , might form a partnership or merge.